Azimzade Y, Haugen MH, Kristensen VN, Frigessi A, Köhn-Luque A (2026)
Explainable machine learning-guided integrated multiomics analysis reveals macrophage-driven immune suppression in breast cancer
Nat Commun (in press)
DOI 10.1038/s41467-026-73617-9, PubMed 42185288

Torland LA, Geisler J, Azimzade Y, Frafjord A, Røed Nilsen H, Buer L, Lømo J, Garred Ø, Tahiri A, Lyngra M, Øynebråten I, Corthay A, Sahlberg K, Kristensen V, Tekpli X (2026)
Multi-platform analysis of the tumor immune microenvironment associated with breast cancer subtypes
Oncoimmunology, 15 (1), 2610535
DOI 10.1080/2162402X.2025.2610535, PubMed 41530924

Billaud A, Figlioli G, Mooser C, Casamassima I, Azzoni V, Srivatsa J, Colombo M, Caleca L, Ahearn TU, Andrulis IL, Antoniou AC, Beckmann MW, Behrens S, Bermisheva M, Bogdanova NV, Bolla MK, Bonanni B, Brüning T, Camp NJ, Campbell A, Castelao JE, Cessna MH, Chang-Claude J, NBCS Collaborators, Czene K et al. (2025)
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
Breast, 85, 104619
DOI 10.1016/j.breast.2025.104619, PubMed 41223770